IN8bio (NASDAQ:INAB – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share for the quarter, beating the consensus estimate of ($0.34) by $0.09, FiscalAI reports. HRT Financial LP bought a new position in shares of IN8bio during the fourth quarter valued at $34,000. HC Wainwright restated a “buy” rating on shares of IN8bio in a research note on Thursday, June 4th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of IN8bio in a research note on Friday, July 17th.